Strides Pharma debuts with stellar ESG rating of 76/100 in S&P Global CSA 2024
Bangalore: Strides Pharma Science Limited has announced that the Company has received an ESG score of 76/100 and CSA score of 75/100 in the Corporate Sustainability Assessment (CSA) Annual Review (vide report dated 20th January, 2025) for its debut submission.
With this achievement, Strides has secured a position in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry. On Customer Relations, the Company achieved 100th percentile. "The Company has demonstrated exceptional performance by achieving an ESG score of 76/100, driven by the Social and Goverence Dimensions, which carry the highest weightage, securing the 97th percentile. In Environment dimension, the Company attained a commendable 87th percentile," Strides stated.
Arun Kumar, Founder & Executive Chairperson, and Mr. Badree Komandur, MD & Group CEO, commented, “We are proud to announce that we have received an industry-leading ESG rating from S&P Global on our debut submission. This accomplishment underscores our unwavering commitment to sustainability. It validates our dedication to responsible business practices and reinforces our ongoing efforts to integrate ESG principles across our business operations. As we continue to strengthen and expand our ESG initiatives, we remain focused on creating a lasting, positive impact for all our stakeholders.”
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.